ACG Boston | C-Series Networking Breakfast: MedTech Panel (Virtual)

Alan Fullerton has been an investment banker to large corporations, middle-market firms and family-owned firms since 1997. Before joining Mirus, he was Managing Director in the investment banking group of Newbury Piret, a regional firm, where he led and managed dozens of M&A and financing transactions in a variety of industries.

Alan is senior advisor to management teams and business owners with significant experience in arranging equity financings ($5 million to $100 million) and executing buy-side and sell-side M&A mandates. Alan has been a sector finalist for several national M&A Advisor Awards for his transactions in industrial services, healthcare, consumer products, business services, travel services, and highly engineered industrial products, including for deals closed with Fortune 500 and Global 500 corporations, private equity-backed companies, closely-held businesses, and middle-market publicly traded companies.

In addition, his advisory experience includes fairness opinions for venture-backed and publicly traded companies; he is a member of the Mirus fairness opinion committee, a position he also held at his previous firm.

Before his investment banking career, he was a member of technical staff and project leader with the 2500-person engineering consulting firm TASC. During his tenure with TASC, he was a project leader on strategic planning, engineering, operations and policy engagements.

Alan holds a BS from M.I.T. in Mechanical Engineering, an MS from Brown University in Electrical Engineering, and an MBA from the Ecole des Ponts of Paris, France. He holds Series 7, 24, 63 and 79 certifications from FINRA.

Alan lives in Lexington, Massachusetts with his wife, son and two daughters. In his spare time, Alan enjoys reading, traveling and playing games with his kids.

Dr. Shantanu Gaur is the co-founder and CEO of Allurion Technologies. Together with his partners, Shantanu has overseen Allurion’s fundraising, research and development, clinical programs, and commercial operations since the company’s inception.
Allurion was founded out of Harvard Medical School and has developed and commercialized the world’s first weight loss platform—including devices, digital therapeutics, and nutritional programs—to help treat obesity. The company has already treated over 40,000 consumers, shed an estimated 1 million pounds, and grown revenues at 100%+ CAGR over the past 4 years.
Allurion’s flagship weight loss program features the Elipse® Balloon—the world’s first and only procedureless gastric balloon for weight loss—the Allurion Virtual Care Suite which includes the Allurion Bluetooth® Connected Scale, Health Tracker smartwatch, and mobile app, and the Allurion “Honeymoon from Hunger” personalized nutritional and behavior change coaching program. On average, consumers lose 30 pounds in 4 months on the Allurion Program.
 
Since Allurion’s inception in 2009, the company has raised over $80 million. The company is headquartered in Natick, MA with offices in Paris, Dubai, and Hong Kong. Allurion has been recognized as one of Fierce Medical Device’s Fierce 15, one of Boston’s 50onFire, and a top Emerging Technology by SAGES.
 
Shantanu is an inventor on over 40 patents and has authored multiple peer-reviewed publications. He has been featured on CNBC and Bloomberg and invited to speak on Allurion, obesity, and medical device innovation at numerous worldwide events.
 
Shantanu graduated summa cum laude with a B.S. in Biology from Harvard College and with an M.D. from Harvard Medical School where he was a Paul Revere Frothingham Scholar and Paul & Daisy Soros Fellow. He lives in Dover, MA with his wife Neha and son Yuvraj.

Jon brings 22 years of experience in private equity, software, and financial services and has worked closely with numerous middle market companies prior to joining the Riverside team in 2004. He currently manages the firm’s intermediary relationships and new investment evaluation.

Prior to joining Riverside, Jon was an investment professional at Fidelity Strategic Investments, the private equity investment division of Fidelity Investments, where he worked on investments in the software, manufacturing, and healthcare industries. Previously, he was the Director of Business Development at Reciprocal, Inc., an enterprise software company that was acquired by Microsoft in 2001. From 1995 to 1999, Jon was a Vice President in Fidelity Investments’ Institutional Services Company. He currently serves as a director for the Boston chapter of the Association for Corporate Growth.

Jon holds a Bachelor’s degree in Business Administration, with distinction, from Emory University, and a Master of Business Administration from The Wharton School of Business at the University of Pennsylvania.